MDM2 and ovarian carcinoma: MiR-646 currently seems involved in cell proliferation and metastasis in a variety of tumors and was reported to mediate the VAMP2 and MDM2 genes at the post-transcriptional regulation level, thereby inhibiting the activity of ovarian cancer cells [27].